Anti-VEGF therapy has revolutionized the treatment of exudative retinal vascular disease. Whereas the first generations of anti-VEGF therapy hoped to improve quality of life through vision maintenance and remediation, newer advancement hope to decrease the burden of treatment while providing comparable visual outcomes. This course will briefly review current paradigms of anti-VEGF therapy before delving into novel anti-VEGF delivery systems and agents.

Course Code:



Daniel Epshtein, O.D.



AOA Expiration Date:


Related News

Be in the know: Optometry's Meeting® 2024 live news

This is the official news page for Optometry's Meeting® 2024. Here, you will find exclusive news coverage with live running news stories.

Primary care of the stroke patient

Two case studies illustrate why primary eye care providers should know the symptoms of stroke and understand the range of visual rehabilitation therapies.

How AOAExcel® makes your life easier

Get to know the program that empowers you with tools to help simplify your practice.